Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Certara Q3 2026 10-Q: 152.5M Shares Outstanding

Certara, Inc. filed its quarterly report on Form 10-Q with the SEC on November 5, 2026, covering the fiscal quarter ended September 30, 2026, disclosing share count, business risks, and a completed divestiture of its regulatory medical writing business.

Anjali Anand | 05 November 2026

Open Text Q1 FY2027 Revenue $1.24B, EPS $0.64

Open Text Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 5, 2026, reporting first-quarter fiscal 2027 financial results including net income of $155.3 million attributable to OpenText.

Aakashdeep | 05 November 2026

Unity Software Q3 2026: Revenue Rises to $622M

Unity Software Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 5, 2026, reporting third-quarter revenue of $622,092 thousand and total assets of $6,964,090 thousand.

Aditi Sarkar | 05 November 2026

OpenText Declares $0.28 Dividend, Reports Q1 FY2027 Results

Open Text Corporation filed a Form 8-K on November 5, 2026, announcing its financial results for the quarter ended September 30, 2026, and disclosing a quarterly cash dividend of $0.28 per Common Share declared by its Board of Directors.

Vinay Lochav | 05 November 2026

Verisk Analytics Q3 2026: Revenue Rises to $809M

Verisk Analytics, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 5, 2026, reporting third-quarter revenues of $809.0 million and net income of $219.2 million.

Manish Choudhary | 05 November 2026

Vistance Networks Q3 2026: Net Income $1.03B on Divestitures

Vistance Networks, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 5, 2026, reporting net income of $1,030.6 million for the third quarter and $6,833.7 million for the nine months ended …

Aakashdeep | 05 November 2026

REGENXBIO Q3 2026 10-Q: 66.1M Shares Outstanding

REGENXBIO Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission for the period ended September 30, 2026, disclosing share count, filing status, and key operational and regulatory risk factors as of November 5, 2026.

Aditi Sarkar | 05 November 2026

C4 Therapeutics Files Q3 2026 Report, 131M Shares Out

C4 Therapeutics, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 5, 2026, disclosing operational details, risk factors, and share count information for the third quarter.

Nitish Kishor | 05 November 2026

Latigo Biotherapeutics Files Q3 2026 Report with 66.3M Shares

Latigo Biotherapeutics, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 5, 2026, covering the fiscal quarter ended September 30, 2026.

Aakashdeep | 05 November 2026

Vistance Networks Adds $100M Buyback, Reports Q3 2026 Results

Vistance Networks, Inc. filed an 8-K with the U.S. Securities and Exchange Commission on November 5, 2026, disclosing a new $100 million share repurchase authorization and the release of its third-quarter 2026 financial results.

Aditi Sarkar | 05 November 2026
Support

Hi! How can we help you today?

Loading…